Company: BOLT
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641281-25-000007
Chunk: 1

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
 30, 2025 and December 2024, respectively

     —

     —

     Additional paid-in capital

     485,852

     484,504

     Accumulated other comprehensive (loss) gain

     (6
     )

     97

     Accumulated deficit

     (447,004
     )

     (427,403
     )

     Total stockholders' equity

     38,842

     57,198

     Total liabilities and stockholders' equity
      
     $
     75,499

     $
     99,632

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.